Nancy Groot

Company: Personalis

Job title: Director - Biopharma Business Development

Seminars:

Personalis: Best-in-Class NGS Partner for Individualised Neoantigen-based Therapy Design and Response Monitoring 4:40 pm

ImmunoID NeXT; multidimensional view of the tumour and the TME from a single sample, including comprehensive neoantigen identification (with accelerated TATs) NeXT Personal; ultra-sensitive, tumour-informed liquid biopsy assay for MRD detection and therapy response monitoring, with simultaneous variant trackingRead more

day: Day One